BackgroundIntraperitoneal local anaesthetic nebulization is a relatively novel approach to pain management after laparoscopic surgery. This randomized, double-blind, placebo-controlled trial evaluated the effects of intraperitoneal ropivacaine nebulization on pain control after laparoscopic cholecystectomy. MethodsPatients undergoing laparoscopic cholecystectomy were randomized to receive intraperitoneal nebulization of ropivacaine 1% (3 ml) before surgical dissection and normal saline 3 ml at the end of surgery (preoperative nebulization group); intraperitoneal nebulization of normal saline 3 ml before surgical dissection and ropivacaine 1% (3 ml) at the end of surgery (postoperative nebulization group); or intraperitoneal nebulization of normal saline 3 ml before surgical dissection and at the end of surgery (placebo group). Intraperitoneal nebulization of ropivacaine or saline was performed using the Aeroneb Pro® device. Anaesthetic and surgical techniques were standardized. The degree of pain on deep breath or movement, incidence of shoulder pain, morphine consumption, and postoperative nausea and vomiting were collected in the post-anaesthesia care unit and at 6, 24, and 48 h after surgery.ResultsCompared with placebo, ropivacaine nebulization significantly reduced postoperative pain (-33%; Cohen's d 0.64), referred shoulder pain (absolute reduction -98%), morphine requirements (-41% to -56% Cohen's d 1.16), and time to unassisted walking (up to -44% Cohen's d 0.9) (P<0.01). There were no differences in pain scores between ropivacaine nebulization groups.ConclusionsRopivacaine nebulization before or after surgery reduced postoperative pain and referred shoulder pain after laparoscopic cholecystectomy. Furthermore, ropivacaine nebulization reduced morphine requirements and allowed earlier mobility. © 2013 Author.

Ingelmo, P., Bucciero, M., Somaini, M., Sahillioglu, E., Garbagnati, A., Charton, A., et al. (2013). Intraperitoneal nebulization of ropivacaine for pain control after laparoscopic cholecystectomy: A double-blind, randomized, placebo-controlled trial. BRITISH JOURNAL OF ANAESTHESIA, 110(5), 800-806 [10.1093/bja/aes495].

Intraperitoneal nebulization of ropivacaine for pain control after laparoscopic cholecystectomy: A double-blind, randomized, placebo-controlled trial

INGELMO, PABLO MAURICIO
;
BUCCIERO, MARIO PAOLO
Secondo
;
SOMAINI, MARTA;SAHILLIOGLU, EMRE;GARBAGNATI, ANDREA;FUMAGALLI, ROBERTO
Penultimo
;
2013

Abstract

BackgroundIntraperitoneal local anaesthetic nebulization is a relatively novel approach to pain management after laparoscopic surgery. This randomized, double-blind, placebo-controlled trial evaluated the effects of intraperitoneal ropivacaine nebulization on pain control after laparoscopic cholecystectomy. MethodsPatients undergoing laparoscopic cholecystectomy were randomized to receive intraperitoneal nebulization of ropivacaine 1% (3 ml) before surgical dissection and normal saline 3 ml at the end of surgery (preoperative nebulization group); intraperitoneal nebulization of normal saline 3 ml before surgical dissection and ropivacaine 1% (3 ml) at the end of surgery (postoperative nebulization group); or intraperitoneal nebulization of normal saline 3 ml before surgical dissection and at the end of surgery (placebo group). Intraperitoneal nebulization of ropivacaine or saline was performed using the Aeroneb Pro® device. Anaesthetic and surgical techniques were standardized. The degree of pain on deep breath or movement, incidence of shoulder pain, morphine consumption, and postoperative nausea and vomiting were collected in the post-anaesthesia care unit and at 6, 24, and 48 h after surgery.ResultsCompared with placebo, ropivacaine nebulization significantly reduced postoperative pain (-33%; Cohen's d 0.64), referred shoulder pain (absolute reduction -98%), morphine requirements (-41% to -56% Cohen's d 1.16), and time to unassisted walking (up to -44% Cohen's d 0.9) (P<0.01). There were no differences in pain scores between ropivacaine nebulization groups.ConclusionsRopivacaine nebulization before or after surgery reduced postoperative pain and referred shoulder pain after laparoscopic cholecystectomy. Furthermore, ropivacaine nebulization reduced morphine requirements and allowed earlier mobility. © 2013 Author.
Si
Articolo in rivista - Articolo scientifico
Scientifica
acute pain; anaesthetic techniques; analgesics; insufflation; local anaesthetics; postoperative; regional; regional techniques; ropivacaine; Adult; Aged; Amides; Analgesics, Opioid; Anesthetics, Local; Cholecystectomy, Laparoscopic; Double-Blind Method; Drug Administration Schedule; Early Ambulation; Female; Humans; Insufflation; Male; Middle Aged; Morphine; Nebulizers and Vaporizers; Pain Measurement; Pain, Postoperative; Perioperative Care; Shoulder Pain; Anesthesiology and Pain Medicine
English
800
806
7
Ingelmo, P., Bucciero, M., Somaini, M., Sahillioglu, E., Garbagnati, A., Charton, A., et al. (2013). Intraperitoneal nebulization of ropivacaine for pain control after laparoscopic cholecystectomy: A double-blind, randomized, placebo-controlled trial. BRITISH JOURNAL OF ANAESTHESIA, 110(5), 800-806 [10.1093/bja/aes495].
Ingelmo, P; Bucciero, M; Somaini, M; Sahillioglu, E; Garbagnati, A; Charton, A; Rossini, V; Sacchi, V; Scardilli, M; Lometti, A; Joshi, G; Fumagalli, R; Diemunsch, P
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10281/75043
Citazioni
  • Scopus 42
  • ???jsp.display-item.citation.isi??? 35
Social impact